Testosterone replacement therapy (TRT) is linked to a significantly lower risk of major CV events in men with secondary hypogonadism.
Researchers present consensus statement for core competencies to guide education for medical students on medical cannabis use.
Investigators compared PSA90 response between new users of apalutamide vs abiraterone for mCSPC using a large US cohort.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback